Anthropic files for Nasdaq IPO, pitching a $40 trillion knowledge-work market
Anthropic dropped its S-1 on October 26, 2026, with plans to list on the Nasdaq as ANT, and it is not thinking small. The Claude maker pitches global knowledge work as a $40 trillion-a-year opportunity and life sciences as a $2 trillion one. First-half revenue hit $16.3 billion, up 14-fold from a year earlier.
- 2 sources report it: cryptobriefing.com, coinpedia.org.
- The source published it on Nov 10, 2026 at 4:28 PM.
Nothing open. Every check passed.
Anthropic filed its S-1 with the SEC on October 26, 2026, setting up a Nasdaq listing under the ticker ANT. The filing comes with numbers that explain the noise: first-half 2026 revenue of $16.3 billion, a 14-fold jump from $1.16 billion in the same stretch a year earlier. Pre-IPO valuation chatter has circled a range of $1.5 trillion to $2 trillion, which would rank the debut among the biggest listings ever if those figures hold at pricing.
Instead of sizing its market off existing software budgets, Anthropic points at global payroll. The filing pegs the total economic value of worldwide knowledge work at more than $40 trillion annually. The company is not claiming it will collect that sum — it argues frontier AI productivity gains will eventually move through the economy at that scale, and it wants to be the infrastructure layer they run on.
The customer list backs up the pitch. Anthropic says more than 11,900 customers spend at least $100,000 a year with the company, a group that includes every Fortune 10 firm and more than half of the Fortune 500.
Life sciences gets its own chapter. Anthropic projects global pharmaceutical spending will top $2 trillion in 2026 and is positioning Claude as a drug discovery and development tool. It put money behind that in April 2026, acquiring Coefficient Bio for $400 million in stock and standing up a molecular biology lab in the Bay Area. Novartis CEO Vas Narasimhan also joined the board, bringing industry weight to the scientific claims.
TopicsAnthropic · Claude · Nasdaq · SEC · Coefficient Bio · Vas Narasimhan · Novartis
Written by Paparazzi with AI. Not financial advice.
More stories
- Tech & AIx.com0viewsHouse Republicans float subpoena for Nvidia CEO Jensen Huang
- Tech & AIengadget.com0viewsNew York recruits 80-plus scientists to test AI models itself
- Tech & AIcryptobriefing.com0viewsAnthropic carves out up to 20% of its Nasdaq IPO for retail investors
- Tech & AIcnbc.com0viewsNvidia board taps Wachtell to probe Jensen Huang over affair and security risk